BSE Live
Apr 16, 16:01Prev. Close
1696.65
Open Price
1707.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 16, 15:59Prev. Close
1696.60
Open Price
1713.90
Bid Price (Qty.)
1693.10 (46)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 5,030.57 | 3,449.65 | 1,741.05 | 306.86 | 2,152.87 | |
| Net CashFlow From Operating Activities | 4,198.77 | -292.42 | 507.08 | 7,636.36 | 1,737.25 | |
| Net Cash Used In Investing Activities | -209.56 | -262.91 | -705.17 | -2,702.10 | -601.80 | |
| Net Cash Used From Financing Activities | -3,831.18 | 473.95 | 169.31 | -4,870.85 | -1,126.29 | |
| Foreign Exchange Gains / Losses | 7.53 | -2.44 | 19.53 | 5.06 | -7.32 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 165.56 | -83.82 | -9.25 | 68.47 | 1.84 | |
| Cash And Cash Equivalents Begin of Year | 326.46 | 410.28 | 419.53 | 351.06 | 220.50 | |
| Cash And Cash Equivalents End Of Year | 492.02 | 326.46 | 410.28 | 419.53 | 222.34 |
17.03.2026
09.03.2026
09.03.2026
04.02.2026
Buy Sun Pharmaceutical Industries; target of Rs 1900: Prabhudas Lilladher
03.02.2026
Sun Pharma Consolidated December 2025 Net Sales at Rs 15,520.54 crore, up 13.49% Y-o-Y
03.02.2026
Sun Pharma Standalone December 2025 Net Sales at Rs 5,687.77 crore, down 8.14% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth